On the one hand, SNKAF decreased the levels of p-PI3K and p-Akt, which in turn targets downstream regulatory markers of apoptosis, like caspase 9, Bax, Bim, Bcl-XL, leading the occurrence of apoptosis in HCC cells. Here, BCL2L11 is linked to hepatocellular carcinoma.